BOSTON — NanoView Biosciences, Inc., and Quantum Design Korea, a subsidiary of Quantum Design International, today announced an exclusive distribution agreement for NanoView’s ExoView™ platform in South Korea. “We are eager to make NanoView’s unique technology for analyzing and characterizing exosomes available to scientists in Korea,” said Manwoong Nam, General Manager of Quantum Design Korea. […]
El Segundo, CA – BioDiscovery, Inc., a leader in innovative genomic software solutions, announced that Children’s Hospital of Los Angeles (CHLA), an award-winning hospital with comprehensive medical care services and programs for children, has signed on as a BioDiscovery Center of Excellence for Clinical Genomics to serve as a reference site for others seeking information […]
MOBILion Systems, Inc. is partnering with Agilent Technologies Inc. to integrate its patented ion mobility separations technology, called Structures for Lossless Ion Manipulation (SLIM), with Agilent’s Q-TOF mass spectrometry platform as the company’s first commercial product offering. MOBILion’s high resolution, high throughput technology combined with Agilent’s high-performance Q-TOF platform provides unparalleled analytical capability, enabling pharmaceutical […]
Strategic agreement utilizes FDA-approved next-generation sequencing Oncomine Dx Target Test to identify RET-altered non-small cell lung cancer and thyroid cancer patients who may be suitable for LOXO-292, Lilly’s RET inhibitor CARLSBAD, Calif. — Thermo Fisher Scientific today announced an agreement with Eli Lilly and Company for development of a companion diagnostic that will use the U.S […]
OAKLAND, Calif.–Clinical genomic testing and next-generation sequencing (NGS) are integral parts of realizing the potential of precision medicine, but the data complexity and technical integrations needed to make genomic data clinically meaningful and routinized have slowed mainstream adoption of these breakthrough technologies. Today, Fabric Genomics, a global leader in clinical interpretation of genomic data, announced […]
Accelerated Technology Laboratories, Inc. (ATL), a leader in Laboratory Information Management Solutions (LIMS), is excited to announce that it will partner with the Economic Development Partnership of North Carolina (EDPNC) and share a booth at the 2019 Water Environment Federation’s Technical Exhibition & Conference (WEFTEC). The Conference will take place September 21-25, 2019 at the McCormick Place Convention Center […]
Indianapolis, IN, September 05, 2019 –(PR.com)– Biosynthetic Technologies (BT) today announced it has signed on with Cayman Chemical for the production and distribution of novel Estolide compounds for pharmaceutical testing applications. BT is excited to partner with Cayman Chemical to provide discovery and pre-clinical development services to the global pharmaceutical, biotechnology, and academic research markets […]
Expansion to include increased royalties and cover additional applications for Company’s technology platform Salt Lake City, Utah – Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, and LGC, Biosearch Technologies (“LGC”), a global leader in the design, development, and manufacture of sophisticated, custom oligonucleotide-based tools and […]
Simulations Plus today announced a new funded collaboration with a clinical-stage biotech to develop an intra-articular delivery model in GastroPlus. New intra-articular injection route will expand the suite of drug delivery options available in GastroPlus® Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer […]
NEW YORK – Schrödinger today announced a collaboration with AstraZeneca to deploy Schrödinger’s advanced computing platform to help accelerate drug discovery efforts. Schrödinger’s computational platform combines physics-based modeling and machine learning to enable chemists to predict the potency of a molecule binding to a target protein. This increases the likelihood that, when synthesized, compounds will have […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
